Lung cancer trials in Türkiye

In Türkiye 82 Also abroad 2746

82 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Where
Adana, Ankara, Diyarbakır, Gaziantep, Istanbul, Samsun, Üsküdar / İstanbul
Age
18 years and over
People
1,410 worldwide
Run by
Pfizer
See details and how to joinNCT07222566 · EU 2025-523461-17-01
Phase 2Taking people
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Where
Adana, Edirne, Esenyurt, Istanbul
Age
18 years and over
People
220 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT05967689
Phase 1/2Taking people
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Where
Ankara
Age
18 years and over
People
327 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06780137 · EU 2024-517926-25-00
Phase 1/2Taking people
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Where
Ankara, Istanbul
Age
18 years to 130 years
People
622 worldwide
Run by
AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00
Phase 2/3Taking people
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Where
Adana, Adapazarı, Ankara, Istanbul, Konya, Samsun
Age
18 years and over
People
490 worldwide
Run by
AbbVie
See details and how to joinNCT07155187 · EU 2025-521124-29-00
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Where
Ankara, Bakırköy, Çankaya, İzmit, Küçükçekmece, Yüreğir
Age
18 years and over
People
830 worldwide
Run by
AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00
Phase 1Taking people
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
Where
Adana, Ankara
Age
18 years to 90 years
People
380 worldwide
Run by
Amgen
See details and how to joinNCT07037758
Phase 3Taking people
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Where
Adana, Ankara, Antalya, Diyarbakır, Gaziantep, Istanbul, Izmir, İzmit, Konya, Seyhan
Age
18 years and over
People
780 worldwide
Run by
Summit Therapeutics
See details and how to joinNCT06767514 · EU 2024-518629-14-00
Phase 3Taking people
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Adapazarı, Ankara, Goztepe Istanbul, Izmir, Küçükçekmece, Seyhan
Age
18 years and over
People
582 worldwide
Run by
AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00
Phase 1/2Taking people
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Where
Adana, Ankara, Istanbul, Sakarya
Age
18 years and over
People
594 worldwide
Run by
BioNTech SE
See details and how to joinNCT06892548 · EU 2024-520238-31-01
Phase 1Taking people
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Where
Adana, Ankara, Izmir
Age
18 years to 99 years
People
160 worldwide
Run by
Amgen
See details and how to joinNCT07531095 · EU 2025-522888-15-00
Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Ankara, Diyarbakır, Istanbul, Izmir
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
Phase 3Taking people
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Where
Ankara, Edirne, Istanbul, Izmir, Kocaeli, Konya, Malatya
Age
18 years and over
People
756 worldwide
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583
No phaseTaking people
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
Where
Samsun
Age
18 years and over
People
142
Run by
Ondokuz Mayıs University
See details and how to joinNCT07500376
Phase 1Taking people
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Where
Adana, Ankara, Istanbul, Izmir
Age
18 years and over
People
320 worldwide
Run by
BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00
Phase 1Taking people
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Where
Adana, Ankara, Istanbul
Age
18 years and over
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00
No phaseTaking people
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy
Where
Ankara
Age
18 years to 75 years
People
40
Run by
Hacettepe University
See details and how to joinNCT07646288
No phaseTaking people
Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)
Where
Ankara
Age
18 years and over
People
400
Run by
Gazi University
See details and how to joinNCT07394062
No phaseTaking people
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
Where
Adana, Afyonkarahisar, Ankara, Antalya, Aydin, Diyarbakır, Edirne, Gaziantep, Istanbul, Izmir, Konya, Mersin, Ordu, Sakarya, Samsun, Trabzon
Age
18 years and over
People
150
Run by
Antalya Training and Research Hospital
See details and how to joinNCT07279402
Phase 2Taking people
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
Where
Adana, Ankara, Antalya, Istanbul, Zeytinburnu
Age
18 years and over
People
60 worldwide
Run by
BioNTech SE
See details and how to joinNCT06841055 · EU 2024-518279-80-00
No phaseNot yet taking people in Türkiye
The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
Where
Elâzığ
Age
18 years to 80 years
People
60
Run by
Firat University
See details and how to joinNCT07520799
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Ankara, Bornova-Izmir, Istanbul
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
Phase 2Not yet taking people in Türkiye
Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)
Where
Istanbul
Age
18 years and over
People
10
Run by
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
See details and how to joinNCT07500285
No phaseNot yet taking people in Türkiye
Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery
Where
Istanbul
Age
18 years to 70 years
People
70
Run by
Saglik Bilimleri Universitesi
See details and how to joinNCT07499986
No phaseNot yet taking people in Türkiye
Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer
Where
Ankara
Age
18 years and over
People
62
Run by
Hacettepe University
See details and how to joinNCT07401056